TER•October 27, 2026 at 11:00 AM UTCSemiconductors & Semiconductor Equipment

Teradyne's AI-Led ATE Surge Confirmed, But Valuation Still Caps Upside

Read source article

What happened

Seeking Alpha upgraded Teradyne citing a 95.3% YoY H1 revenue surge, new product launches, hyperscaler wins, and a projected 46.3% annual Semiconductor Test growth through 2030. The article acknowledges the stock's 110% run-up and recent 22.56% pullback, noting a 21.76% upside to its target, yet concedes much of the bullish outlook is already priced in. Our master report already captured these strong trends: Q2 revenue of $1.329B, Semiconductor Test at $1.122B, and memory revenue above $200M for a third straight quarter. However, the report also flagged a sequential guidance step-down for Q3 and operating margin contraction from 36.9% to 32.9%, which the article does not address. Consequently, the new information reinforces the demand story but does not resolve the margin durability concern that underpins our WAIT rating.

Implication

The article's bullish tone likely reflects already-known demand strength, so it offers little new fundamental insight. With TER trading at 49.6x P/E and 73.8x EV/EBITDA, the market is discounting a prolonged AI-driven upcycle with no room for error. Our base case value is $360, roughly in line with the current price, implying limited upside. A pullback to below $315 would provide a more attractive risk/reward, aligning with our stated entry level. Additionally, investors should watch for Q3 results versus guidance, memory revenue staying above $200M, and operating margin recovery above 35% to signal that the durability thesis is intact.

Thesis delta

The new article corroborates strong ATE demand but adds little beyond known Q2 results; the core WAIT thesis remains intact. The highlighted 46.3% forward segment growth is aggressive and assumes sustained AI capex without margin erosion, which we view skeptically. No rating change is warranted; we maintain WAIT and continue to monitor for a pullback to ~$315 or evidence of operating margin recovery above 35%.

Confidence

Medium-High